Whether lost in a 30-year-old data set or a 1,000-year-old leech book, scientists are using new machine learning and AI tools to find promising drugs lost to time. Stephanie DeMarco, PhD explores this and more in a new editorial: https://ow.ly/KnWk50UfMku
Drug Discovery News
图书期刊出版业
Wilmington ，Delaware 7,943 位关注者
Exploring drug discovery and development
关于我们
Drug Discovery News provides engaging stories about scientific breakthroughs that will help life science researchers develop diagnostic and therapeutic approaches for improving human health. Read the latest drug development news at drugdiscoverynews.com.
- 网站
-
https://drugdiscoverynews.com/
Drug Discovery News的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Wilmington ，Delaware
- 类型
- 私人持股
- 创立
- 2005
- 领域
- drug discovery and development、life science research、pharmaceuticals、biotechnology、publishing、clinical trials、biopharmaceuticals、diagnostics、biomarkers、cancer research、journalism、translational research和preclinical research
地点
-
主要
获取路线
1000 N West Street, Suite 1200
US，Delaware，Wilmington ，19801
Drug Discovery News员工
-
Rajesh Kumar
News Editor/ Reporter at DDNews
-
Hannah Thomasy
Fellowship in Global Journalism at Dalla Lana School of Public Health, University of Toronto
-
Nidhi kumar
Celebrity show host on Indias public broadcaster at DD NEWS and DD NATIONAL, Ministry of Science, and Technology, Media lead and ambassador at Mitron…
-
Vikas pal singh
Asstt.Producer at DD NEWS
动态
-
Researchers found that the synchronization of brainwaves between three brain regions correlates with the enjoyment of music and the lessening of depressive symptoms. Read more: https://ow.ly/50GI50UbT0v
-
-
CAR T cell therapy can fight leukemia and lymphoma, but many patients experience relapse. Massachusetts Institute of Technology and Harvard University scientists have teamed up to create a new tracking tool to predict when the treatment might fail, Andrew Saintsing reports. Read more: https://ow.ly/aNPa50Ub59B
-
-
Current treatments for neuropathic pain struggle to provide fast acting and long-term relief for symptoms of the disease. A recent study from researchers at Icahn School of Medicine at Mount Sinai highlighted an antidepressant that could give the best of both worlds. Read more: https://ow.ly/hLKH50Uauoi
-
-
Scientists are repurposing existing drugs to treat ichthyosis, a rare genetic skin condition. Read more: https://ow.ly/WIrp50UatBi
-
-
Terazosin, a medication for prostate enlargement, appears to protect patients from Parkinson’s disease. Now, researchers at Weill Cornell Medicine have shown how the drug’s off-target interactions help neurons, Andrew Saintsing reports. Read more: https://ow.ly/c8xz50UasPy
-
-
In a high-throughput screen of repurposed drugs, Michael Bollong and his team at Scripps Research identified a drug that turns back time on aged lung stem cells. It may be a new treatment for idiopathic pulmonary fibrosis that targets the disease directly at the source, he told Stephanie DeMarco, PhD. Read more: https://ow.ly/tbZp50U9wsZ
-
-
Sanofi’s new oral TNFR1 inhibitor, SAR441566, shows promise in treating rheumatoid arthritis. We spoke with the company’s Head of Immunology and Inflammation, Elizabeth Laws, on how she and her team aim to replace less effective injectables with this new oral option. https://ow.ly/McCF50TXtCp
-
Oral bacteria to the rescue! Researchers found that the oral bacterium Porphyromonas gingivalis secretes compounds that can inhibit SARS-CoV-2 infection, providing new avenues for developing antiviral therapies. Learn more: https://ow.ly/kezT50U7aJl
-
-
Parkinson’s disease isn’t diagnosed until after the brain has already been damaged. Researchers are working to diagnose Parkinson’s disease earlier to prevent neurodegeneration and treat patients sooner. Learn more: https://ow.ly/gu8Q50U4rOI
-